Using stem cells to study rare growth disorders
Part of Genetic & congenital clinical trials.
This study looks at rare growth conditions (Silver-Russell, Beckwith-Wiedemann, and Temple syndrome) by creating lab cell models from patient information. It aims to help researchers better understand why these disorders happen and how they work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Silver-Russell syndrome, Beckwith-Wiedemann syndrome, or Temple syndrome
- You are a minor or a young adult (treated in the study department)
- If you are a minor, your weight is at least 5 kg
- You can clearly agree to allow use of your personal data for the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at gene methylation patterns in people with certain growth conditions. It aims to better understand how these changes relate to Beckwith-Wiedemann syndrome, Silver-Russell syndrome, and Temple syndrome.
This study looks at how young adults aged 15–25 with rare genetic conditions (like certain bone, skin, hearing, or facial conditions) are doing in school, work, and social life. Researchers want to understand what helps or prevents young people with these conditions from being included in their communities.
This study is looking for people with rare, unexplained conditions that cause early intellectual disability and low muscle tone. Researchers want to study your cells and blood to try to find new genetic causes that standard DNA tests missed.
This study looks at how to create laboratory models of genetic diseases using stem cells made from people’s cells. It may help researchers understand disease causes and how treatments could work, using genetic patients (and some non-patient controls).
This study is for people who have a rare syndrome or rare congenital condition and are seen at a rare-disease clinic. It aims to better understand these conditions and how care works in a team setting, which may help guide future treatment decisions.
This study uses genome (DNA) sequencing to look for the genetic cause of rare disorders, especially when the cause is unknown. It may help some families better understand what is driving the condition, using genetic information from the affected person and often their parents.
Hear when a new Induced Pluripotent Stem Cells trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.